共 325 条
[1]
Roupret M(2023)European Association of Urology Guidelines on Upper urinary tract Urothelial Carcinoma: 2023 update EUR UROL 84 49-64
[2]
Seisen T(2023)Cancer statistics, 2023 CA-CANCER J CLIN 73 17-48
[3]
Birtle AJ(2023)Upper tract urothelial carcinoma in Germany: epidemiological data and surgical treatment trends in a total population analysis from 2006 to 2019 WORLD J UROL 41 127-33
[4]
Capoun O(2021)Outcome prediction following radical nephroureterectomy for upper tract urothelial carcinoma UROL ONCOL-SEMIN ORI 39 133-9
[5]
Comperat EM(2019)Outcomes of stage II-IV upper-tract urothelial carcinoma and adjuvant chemotherapy for locally advanced cancer ONCOL LETT 17 1341-8
[6]
Dominguez-Escrig JL(2020)Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial Lancet 395 1268-77
[7]
Gurses AI(2017)Effectiveness of Adjuvant Chemotherapy after Radical Nephroureterectomy for locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma J CLIN ONCOL 35 852-60
[8]
Liedberg F(2023)Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and cisplatin in Advanced or metastatic bladder Cancer: results of a large, randomized, multinational, Multicenter, Phase III Study J CLIN ONCOL 41 3881-90
[9]
Mariappan P(2021)Recent advances in neoadjuvant immunotherapy for urothelial bladder cancer: what to expect in the near future CANCER TREAT REV 93 102142-14
[10]
Hugh MA(2021)Adjuvant Nivolumab versus Placebo in muscle-invasive Urothelial Carcinoma NEW ENGL J MED 384 2102-76